Future of Novo Nordisk, Lundbeck and Ascendis Pharma trials in Ukraine remains unclear
Ukraine is home to many clinical trials being run by big Danish pharmaceutical companies, but it’s too early to tell whether development time lines will be impacted by the war.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
As Russia continues its attempts to take over Kyiv, pharmaceutical companies take stock of how the war might impact drug development plans.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
